Guidance on PFAS Testing and Health Outcomes Meeting 5

July 13, 2021

Per- and polyfluoroalkyl substances (PFAS) are chemicals with almost ubiquitous exposure in the US—leading to concerns about who should be tested for exposure to PFAS and then if testing occurs, how those results should inform clinical care. The Agency for Toxic Substances and Disease Registry and the National Institute of Environmental Health Sciences have sponsored a study that will provide advice for clinicians about PFAS testing, such as when to test, whom to test, how to test, what to test for, and the risks of testing. In this meeting, the committee will hear from experts on the contribution of PFAS exposure sources to human exposure, clinical principles for advising patients on exposure reduction, putative health effects of PFAS, and methods for evidence synthesis.

Day 1 (7/13) of the meeting will begin at 1:30 PM ET and end at 4:30 PM ET

To register for public comment on the first day (4:00-4:30) please register here

Day 2 (7/14) of the meeting will begin at 1:00 PM ET and end at 5:00 PM ET

To register for public comment on the second day (4:25-4:55) please register here

There will be no public chat box during the webcast; please use the email address listed below if you wish to contact us.

If you require technical assistance for the webinar, please follow the link below: